Dicyclomine Hydrochloride Capsule
FDA Label NDC 0904-6987

42 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Dicyclomine Hydrochloride (NDC 0904-6987). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2 dosage and administration, 2.1 oral dosage and administration in adults, 3 dosage forms and strengths, 4 contraindications, 5.2 cardiovascular conditions, 5.3 peripheral and central nervous system, 5.4 myasthenia gravis, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-6987-61

Unit Dose

Dicyclomine

Hydrochloride

Capsules, USP

10 mg

100 CAPSULES (10 x 10)

Rx only

10mg Carton Label (Af403376 506f 4533 Bae5 Bbfde5aecf05 01)

10mg Carton Label (Af403376 506f 4533 Bae5 Bbfde5aecf05 01)

MAJOR®

NDC 0904-6988-61

Unit Dose

Dicyclomine

Hydrochloride

Tablets, USP

20 mg

100 TABLETS (10 x 10)

Rx only

20mg Carton Label (Af403376 506f 4533 Bae5 Bbfde5aecf05 00)

20mg Carton Label (Af403376 506f 4533 Bae5 Bbfde5aecf05 00)

* Please review the disclaimer below.